NAADAC in HAWAII
May 31 - June 1, 2017 | 8.30am - 4.30pm
Join NAADAC in Honolulu for two days of trainings. On May 31, Darryl Inaba, PharmD, CATC V, CADC III will present Understanding Marijuana: Pharmacology and New Findings. On June 1, Kevin McCauley, MD and Eric Schmidt, MBA, MSW will present Application of Dialectical Behavioral Therapy to Substance Use & Mental Health Disorders. Earn 7 CEs per day or 14 CEs total!
Cost (both days): $150 NAADAC Members/ $180 Non-Members
Cost (one day only): $100 NAADAC Members/ $125 Non-Members
The Queen's Medical Center
1301 Punchbowl St
Honolulu, HI 96813
May 31, 2017
Understanding Marijuana: Pharmacology and New Findings
A growing body of medical evidence demonstrates marijuana (THC) in its current highly potent, newer concentrated forms (“edibles" and "BHO”), and especially the new synthetic cannabinoids (“Spice”) results in major medical and mental health problems. Evidence of increased risks for psychosis, schizophrenia, heart attacks, seizures, hyperemesis syndrome, decreased IQ, and even testicular cancer has been associated with cannabis abuse. This session will look at marijuana as a drug, current findings of its effects, new forms of abuse, its botany, chemistry, pharmacology and its major effects on the brain and body.
Darryl S. Inaba, PharmD, CATC V, CADC III
, is the Director of Clinical and Behavioral Health Services for the Addictions Recovery Center and Director of Research and Education of CNS Productions in Medford, OR. He is an Associate Clinical Professor at the University of California, Special Consultant, Instructor, at the University of Utah School on Alcohol and Other Drug Dependencies, and a Lifetime Fellow at Haight Ashbury Free Clinics, Inc. Inaba has authored several papers, award winning educational films and co-authored Uppers, Downers, All Arounders a text on addiction and related disorders that is used in more than 400 colleges and universities. He has been honored with over 90 individual awards for his work in the areas of prevention and treatment of substance abuse problems.
June 1, 2017
Application of Dialectical Behavioral Therapy to Substance Use & Mental Health Disorders
Kevin McCauley, MD and Eric Schmidt, MBA, MSW will host an interactive presentation about Dialectical Behavioral Therapy and its application to clients with co-occurring mental health and substance use disorders. Attendees will learn the clinical attributes of clients with dual-diagnosis, including behavioral and neurological etiology. Participants will learn and observe a role-play of a DBT strategy, validation. Participants will receive an overview of contingency strategies. A large amount of the presentation will be a demonstration of one of the five core modes of DBT, the Consultation Team. This will include a DBT mindfulness exercise and videos of an actual Consultation Team meeting, allowing the attendees to observe the actual application to DBT. The presenter will highlight the role of neuropathology in BPD symptomatology throughout the lecture.
Kevin McCauley, MD
, is a graduate of Drexel University Medical School and received his Naval Flight Surgeon training at the Naval Aerospace Medical Institute, where he served as a flight surgeon for the Marine Corps Air Station. Following his military service, McCauley was the Director of Le Mont, a sober living and recovery management program in Sandy, UT, and was president of the Utah Association of Recovery Residences. He is currently the Director of Program Services at New Roads Behavioral Health in Salt Lake City, UT. As co-founder of the Institute for Addiction Study, McCauley wrote and directed two films, “Pleasure Unwoven” about the neuroscience of addiction, and “Memo to Self” about Recovery Management in commercial airline pilots and professionals with substance use disorders.
Eric Schmidt, MBA, MSW,
has served in key executive level positions in the behavioral health and substance use disorder field for the past 27 years. He has received both an MSW and an MBA. He has extensive clinical experience working with addiction, borderline personality disorder, trauma, and post-traumatic stress disorder. Schmidt is adjunct faculty for the University of Utah School of Social Work, where he teaches clinical and professional development courses. Currently, he co-owns and serves as the CEO of New Roads Behavioral Health, which serves clients with severe persistent mental illness, addiction, and personality disorders. He is the President of the Utah Association of Addiction Treatment Providers. He also serves as a member of several national organizations for behavioral health.